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Practice Points 
• In the last decade the health profile of care home residents has changed, with greater levels of 
morbidity and a high prevalence of diagnosed and undiagnosed dementia and memory problems. 
• Studies exploring pain in this setting have identified differing rates of prevalence; it is estimated 
that approximately half of care home residents experience pain to some extent. 
• A reactive approach to pain assessment may not be adequate due to individual difficulties in 
self-reporting pain and limitations in current pain assessment methods and practice. 
• Changes in activities of daily living or behaviour, such as presence of agitation, may be indicative 
of pain, and therefore an improvement in these areas following analgesia could be used as a 
treatment outcome 
• Epidemiological research has identified the most common causes of pain in this population, how 
each type of pain is experienced differently and the implications for tailored pain management. 
• Paracetamol is recommended as the first-line therapy with a stepwise approach to meet patient 
needs. While opioids and NSAIDs have risks, the latter has a worse safety profile for this 
population. These recommendations are reflected in current prescribing practices. 
• Prescribing for neuropathic pain does not match the prevalence of this type of pain, which may 
indicate under-treated pain 
• People with dementia and cognitive impairment no longer appear to be prescribed fewer 
analgesics than residents without dementia but may be at risk of under treatment if prescribed 
medication ‘as required’. 
Abstract 
Care home residents are often frail with multiple co-morbidities and cognitive impairment, most 
commonly caused by dementia.  This population is under-represented in clinical trials, leading to a 
lack of valid and reliable evidence to inform clinicians’ prescribing practice.  This paper summarises 
how epidemiological research conducted in similar populations can inform pain management by 
describing pain prevalence, risk factors, typical features and functional consequences. This evidence 
can help overcome the numerous barriers to optimal pain management in care home residents.  
Keywords  
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Care home residents - an increasingly dependent population 
As most people age they develop increasing physical and mental co-morbidities. These include frailty, 
poor mobility, or conditions leading to cognitive impairment, which can make independent living too 
challenging and lead them to move into a care home. The term care home is used here to describe 
an institution providing accommodation, full board, round-the-clock staffing (residential home), and 
sometimes 24-hour nursing care (nursing home). Data has been drawn from recently published 
studies that include samples representative of the general care home population; inclusive of 
those with cognitive impairment, and excluding those living in sheltered or assisted living as 
typically these residents have different needs. Despite the ageing population, the number of care 
home beds has remained stable in recent years [1, 2], but the health profile of residents has changed 
resulting in increasing levels of morbidity and dependency [3, 4]. 
 
The aim of this report is to present current epidemiological data that can be utilised by clinicians 
working with care home residents. Large cross-sectional studies were used to provide data on 
analgesic prescribing patterns. Databases such as Minimum Data Set [5] or interRAI instrument [6] 
indicated the prevalence of pain in older adults. A limitation of these databases is that the quality 
of observations is dependent upon the carer’s ability to assess pain, and pain prevalence is higher 
when self-report methods are used [7]. Smaller studies provided richer data in terms of how pain 
is experienced and could help guide treatment decisions [8, 9]. These more detailed care home 
studies can be harder to set-up and recruiting representative samples of care home residents 
(particularly those with cognitive impairment) can be challenging, especially when conducting 
randomised controlled trials. Furthermore, the use of different research protocols that account for 
the levels of polypharmacy and co-morbidities can impair comparability [10, 11]. 
Prevalence of pain in care home residents 
Pain can be broadly separated into two types: nociceptive, caused by damage to body tissue and 
usually described as sharp, throbbing or aching or neuropathic, caused by nerve damage and usually 
described as tingling, burning, or shooting. Pain can be acute or persistent (lasting three months or 
longer). Typical locations of persistent non-malignant pain in older people include the back, leg, and 
joints [12].  
Due to differences in definitions and methodologies, it is challenging to determine the true 
prevalence of pain for in care homes. A recent and large study conducted by Lukas and colleagues 
from 2009-2011 in European nursing homes found that 48.4% of residents experienced pain to some 
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extent, with assessment involving interview, observation, or prescription of an analgesic [6]. Takai et 
al. found similar results of around 40-60% in their systematic review of pain prevalence studies using 
mixed method assessments [7]. Pain was found to be highest in Finland (73%) and Czech Republic 
(55.5%), and lowest in Israel (19.8%) and Italy (23%). Inter-country differences may reflect a contrast 
in nursing home admission criteria [6], or prescribing rates. Twelve per cent of residents stated their 
pain was not being controlled [6]. A US study found 26.4% of nursing home residents experienced 
persistent pain, and of those in pain, 23% received no regular analgesic medication [5]. A study 
conducted in Germany in 2012 reported pain in 73.2% of nursing home residents, with 14.2% 
receiving no analgesics, and two-thirds of those in pain did not receive analgesic medication that 
adequately matched the type or severity of their pain (without need for potentially harmful drugs) 
[13, 14]. Persistent pain affects quality of life, cognition and activities of daily living [15, 16], and it is 
concerning that residents may be at risk of under-recognition and under-treatment for pain [17-19]. 
Assessing pain in care home residents 
Potential barriers 
Verbal self-report is considered the gold standard of pain assessment. Care home clinicians can take 
a reactive approach, reviewing residents following staff referral for pain, development of a clinical 
problem or if a resident requests medical attention. This may lead to underestimation of pain 
prevalence, as it is reliant on self-report, not necessarily accounting for the barriers identified to 
assessing pain. There is a tendency for older adults to normalise pain as part of ageing, or avoid 
bothering staff, leading to reluctance to seek treatment [20]. Furthermore they may have difficulties 
in verbalising their pain, or engaging fully in assessment, due to changes in vision, hearing or 
cognition [12].  
The impact of dementia 
Although there is a diagnosis rate of only 36.4% in English care homes [6], up to 80% of UK care 
home residents have a form of dementia or memory problems [21], with similar findings in other 
European countries [6]. Self-reporting pain can be challenging or impossible for cognitively impaired 
residents who may lack the memory, abstract thinking or communication ability to tell staff about 
their pain [22], especially if it is intermittent. Sub-optimal pain assessment and treatment in people 
with dementia may be due to the belief that those with dementia feel pain less than those without 
dementia [23]. Reviews (of experimental studies) report mixed effects of dementia on pain 
perception, but it appears that pain processing is not diminished in people with Alzheimer’s disease 
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[24]. Data from the SNAC-K study in Sweden indicated that the prevalence of pain-related diagnoses 
was very similar between institutionalised people with dementia and those without dementia (46% 
vs. 45%) [25]. Pain assessment tools are not always appropriately implemented or reliable indicators 
of whether an individual is experiencing pain or discomfort [26, 27]. In these circumstances, 
clinicians or staff may have to rely on physical or behavioural indicators such as grimacing or 
moaning [26] and if these expressions are not recognised, or if this is not undertaken carefully, then 
a resident may remain in pain. In recent years there has been a much-needed growth in literature 
discussing how best to assess pain in people with cognitive impairment [23, 28].  
Pain can affect a resident’s mood, and they may appear depressed, apathetic, agitated or anxious. 
Pain can also lead to changes in body language and appetite, impaired psychomotor functioning and 
diminished quality of sleep [29-31]. It is difficult for observers to distinguish behaviour caused by 
pain from agitation as a “normal” consequence of dementia [32]; misinterpretation can lead to a 
prescription of psychotropic medication, which is known to have serious adverse effects and does 
not address the underlying cause [33]. Husebø and colleagues tested a stepwise approach to pain 
management in nursing home residents with moderate to severe dementia with agitation and found 
significant improvements in pain, agitation (especially verbal) and depression [32, 34]. Conversely, 
for residents with severe dementia, it has been suggested that observation scales may falsely 
identify pain, as the behaviours measured are indicative of pain but can also result from causes such 
as psychosocial distress [35]. 
Causes of pain in care home residents- what recent epidemiological studies tell us 
Painful diseases commonly affecting care home residents have been identified as musculoskeletal 
disorders, pressure sores, cancer and neuropathies [33, 36, 37]. Here we examine the prevalence of 
leading causes of non-malignant pain in care homes considering studies mainly published in the last 
five years. A recent and global review estimated that 30.2% of the residential care home population 
are affected by musculoskeletal pain [38], and alongside osteoporosis (19.1%) and back pain, 
arthritis (21.1%) is one of the most prevalent causes [39, 40]. Risk factors for osteoporosis and 
osteoarthritis include female gender and old age [41, 42], characteristics typical of care home 
residents. Osteoporotic back pain usually has a gradual onset as a result of vertebral compression 
fractures, but can be more acute and severe, and lead to painful fractures [43, 44]. There are two 
types of nociceptive pain associated with osteoarthritis (generally in the relevant joint): a deep ache 
in the background, and a more intermittent and severe pain [45, 46]. This pain can be aggravated by 
walking and weight-bearing, leading to less participation in related activities [47].  
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Neuropathic pain can result from stroke or diabetes, morbidities commonly found in care homes and 
those with dementia [48, 49]. This type of pain can be difficult to diagnose, and may be less familiar 
to medical staff [8]. It is estimated that 26.4% of diabetic patients have painful diabetic peripheral 
neuropathy [50]. Central pain, caused by stroke, has been argued as the most undertreated type of 
pain [8]. It often presents as dysaesthesia or allodynia, and can be ongoing or intermittent. Pain 
characteristics and locations vary, but frequent descriptions are “burning”, “aching” and “pricking” 
[51, 52]. One study including 275 stroke patients able to self-report found that 45.8% of patients had 
developed new pain 6 months post-stroke [53]. Intervals between stroke and onset of pain have 
been reported to be up to 34 months [51]. A study conducted in nursing homes found 10.9% of 
residents experienced neuropathic pain and 5.6% had possible neuropathic pain. However this study 
excluded those with cognitive impairment, and used medical records to assess presence of pain, so 
this figure may be lower than the actual prevalence in the care home population [54].  
The SHELTER study found pressure sores in 10.1% of nursing home residents [55]. Pain caused by 
pressure ulcers can be neuropathic and nociceptive. The prevalence of pain at pressure ulcer sites 
was found to be 77.2% but in this study, only 39.7% of residents received scheduled analgesics [37]. 
Interestingly, one hospital-based study found that 12.6% of patients with no observable pressure 
ulcer also felt pain at an ‘at risk’ site despite no obvious tissue damage [56].  
Thus epidemiological studies inform us that when assessing care home residents clinicians should 
bear in mind co-morbidity, have a high index of suspicion regarding pain and adopt a proactive 
approach to identifying the most common pain-related diagnoses [33, 57].  
Concerns related to prescribing analgesics for the care home population 
Due to the heterogeneous nature of care home residents and their sources of pain [58] as well as a 
dearth of research [59], there is a limited evidence base for the use of analgesic medication in this 
population [23]. Medication that is effective in younger people may be beneficial but tolerability and 
safety for those who are frail, elderly, and potentially cognitively impaired must be considered [60, 
61].  
For nociceptive pain, it is advised that paracetamol (acetaminophen) is used as first-line 
pharmacologic therapy as it is safe and effective in the management of mild to moderate pain [12, 
61, 62]. If paracetamol is insufficient then further analgesics can be added in a stepwise approach, 
introducing topical agents, non-steroidal anti-inflammatory drugs (NSAIDs), adjuvant analgesics and 
opioids. NSAIDs should be used with caution in older people (risk of gastrointestinal bleeding and 
Page 5 of 15
https://mc04.manuscriptcentral.com/fm-pmt
Pain Management
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
5 
 
impaired renal functioning) [12, 33, 61]. Anticonvulsants are used for neuropathic pain but are 
affected by impaired renal function and can cause drowsiness and sedation [12, 33]. Anti-
depressants are also used for neuropathic pain and should be titrated from low starting doses [8]. 
Opioids are advised for use after all other pharmacologic approaches have been tested, including 
combination therapies, however concerns around the use of opioids in older adults are well 
documented and include drowsiness, nausea, vomiting and constipation [12]. Current guidance does 
not distinguish between those with and without cognitive impairment [33, 63] despite a reluctance 
from clinicians to prescribe opioids to frail and cognitively impaired residents. Moreover, it has been 
suggested that people with dementia may require a higher dosage of analgesic medication due to 
lack of placebo effect and the association between pain and agitation [24]. 
What epidemiological studies tells us about use of analgesics in care homes 
It is often perceived that care home residents, especially those with dementia, are undertreated for 
pain [40], and this was typically found in older studies [64, 65]. Current research demonstrates this is 
not still the case, but most work in this field has come from Nordic countries and may not be 
representative of other countries. Sandvik et al. reported that, in line with a consistent increase in 
analgesics, prescription rates of regular paracetamol had doubled over the last decade in Norwegian 
nursing homes to 48.4% [66]. Several studies have shown that people with dementia are more likely 
to receive paracetamol than people without dementia (45.2% vs. 27.4%) [67, 68]. Worldwide, 
paracetamol appears to be, by far, the most frequently used analgesic drug in care homes [19, 69, 
70], with the exception of Germany where dipyrone (metamizole) was most commonly prescribed 
[71]. Dipyrone is not approved for chronic pain unless other drugs are not indicated, and is banned 
in several countries due to its potential to cause blood disorders such as agranulocytosis [72]. 
Prescription of NSAIDs has decreased in the Scandinavian care home population, down from 9.1%-13% 
in 2003-4, to 2.6%-3.2% in 2011 [4, 66]. 
Insert Table 1 approximately here 
A general practice database study of most of the older Danish population found that for home-
dwellers, people with dementia used opioids more frequently, however within the nursing home 
population, people with dementia were less likely to receive opioid medication than residents 
without dementia [40]. One study reported a significant increase in opioid treatment in Finnish 
nursing home residents, from 11.8% in 2003 to 22.9% in 2011, with similar prescription rates in 
England (22.4% in 2009) and Norway (23.8% in 2011) [4, 49, 66]. The Norwegian study also observed 
an increase in the use of strong opioids from 1.9% in 2000 to 17.9% in 2011 [66]. Pitkala and 
Page 6 of 15
https://mc04.manuscriptcentral.com/fm-pmt
Pain Management
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
6 
 
colleagues suggested the high prevalence of opioid prescribing may indicate that these drugs are not 
being used solely for the treatment of moderate to severe pain [4], and it is speculated that opioids 
may be prescribed to “treat” behavioural symptoms [40]. This could unnecessarily cause negative 
side effects in older adults, for whom there is a limited evidence base for opioid use [12, 40]. 
Concerns have been raised regarding whether prescription of analgesic medication is appropriately 
tailored and sufficiently evaluated to best manage the type of pain experienced by each resident 
[73]. Despite the suspected prevalence of neuropathic pain in nursing home residents, adjuvant 
therapies were only prescribed regularly for 3.8% of the study population [66], possibly indicating 
that this type of pain is being managed inappropriately. While studies including entire populations 
lack problems with selection bias [40], a limitation is that they cannot offer detail on the type or 
severity of the pain. 
Pain relief is often prescribed ‘as required’ (PRN), which is reliant on the assessment skills of care 
staff, or the ability of the resident to communicate pain. There is limited research exploring actual 
administration of PRN analgesia however earlier studies have shown that cognitively impaired 
residents are less likely to receive PRN pain medication [74, 75]. An Irish study found that care home 
residents with dementia were more likely to be prescribed PRN than regularly scheduled analgesics, 
also noting a lack of guidelines regarding pain assessment prior to administering pain relief [76]. 
Recent studies (see Table 1) found that 16.0%-90.7% of care home residents were prescribed 
scheduled or PRN analgesics [70, 76, 77], but when studying only those with a scheduled 
prescription, the range of prevalence decreased to 32–62.8%, with both upper rates taken from the 
same Australian study, with authors referencing changes to national pain management guidelines 
and recent pharmacist review as possible factors influencing the high prescribing rate [69-71, 78], as 
well as individual physician practice and nursing home variability. It is worth noting that the low 
analgesic rate observed in Italy (16%) has been followed by a systemic drive to improve prescribing 
quality, where antipsychotic drug use is high [77]. These rates appear to represent the extremes of 
current analgesic prescribing, reported to be 28% in one European database study (minus Italy), and 
49% in Sweden, with 33% of paracetamol and 48% opioid prescriptions for people with dementia 
administered PRN [25, 77]. Considering around half of the care home population may be in pain [6, 
25], this indicates that pain may remain undertreated.  
Conclusion  
Identifying pain in care home residents can be challenging due to sensory and communication 
problems, with a high percentage of residents living with cognitive impairment [6, 12]. 
Page 7 of 15
https://mc04.manuscriptcentral.com/fm-pmt
Pain Management
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
7 
 
Epidemiological studies have provided valuable information on pain prevalence within care homes, 
estimating that approximately half of the population experience pain [6]. Common pain-related 
disorders include musculoskeletal disorders, pressure sores, cancers and neuropathies [33, 36, 37]. 
Taken with more in-depth research it has been possible to estimate the prevalence of pain within 
each disorder, and how pain is typically experienced. This research could be adapted so that all care 
home residents undergo detailed assessment for painful conditions to inform tailored pain 
management programmes.  
Recent studies have suggested that analgesic prescribing is the highest it has ever been in care 
homes, especially for those with dementia who have historically been perceived as undertreated. 
More research is needed to build a stronger evidence base for analgesic use in the care home 
population. While paracetamol is the most frequently prescribed analgesic [19, 69, 70], there has 
been an increase in opioid prescription rates, which may be due to reduced prescription of NSAIDs in 
response to safety concerns. However residents suffering with neuropathic pain may be at risk of 
under-treatment, as the level of prescribing for adjuvant medication does not appear to match the 
prevalence of this type of pain [4, 66]. 
Future perspective 
Adequate pain management can improve quality of life and functioning in care home residents, and, 
particularly for those with dementia, decrease the use of harmful antipsychotic medication, which 
may be prescribed as a response to pain-induced agitation [34]. Further epidemiological studies may 
offer a more detailed picture of how quality of life, functioning, and neuropsychiatric symptoms are 
influenced by either the addition of analgesics or adjuvant medication, an increase in analgesia using 
an individualised stepwise approach or more rational PRN prescribing.  
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Table 1. Key studies published since 2012 on analgesic prescribing to care home residents 
Author and year Year data 
collection 
ended 
Country n Number 
of care 
homes 
% of residents 
taking opioids 
% of residents 
taking 
paracetamol 
% of residents 
taking any 
analgesic 
Administration: 
regular only 
(regular) or 
regular and PRN 
both 
Sandvik et al., 2016 [66] 2000 Norway 1926 251 10.9 22.7 34.9 regular 
Pitkala et al., 2015 [4] 2003 Finland 1987 nk* 11.8 34.3 - regular 
Sandvik et al., 2016 [66] 2004 Norway 1163 26 9.8 35.7 45 regular 
Kruger et al., 2012 [78] 2008 Norway 513 7 14.6 - 40.2 regular 
Kruger et al., 2012 [78] 2008 Norway 513 7 - 38.4 - both 
Shah et al., 2012 [49] 2009 UK 10387 nk 22.4 37.6 - both 
Halvorsen et al., 2012 
[79] 
2009 Norway 
2986 nk 12.4 40.3 - 
regular 
Sandvik et al., 2016 [66] 2009 Norway 850 18 25.1 42.7 53.5 regular 
Whitney et al., 2012 [80] 2010 England 240 7 7.9 - - both 
Kolzsch, et al., 2012 [71] 2010 Germany 560 40 - - 32 regular 
Jensen-Dahm et al., 2015 
[40] 
2010 Denmark 42291 nk 41 - - both 
Pitkala et al., 2015 [4] 2011 Finland 1576 nk 22.9 46.7 - regular 
Sandvik et al., 2016 [66] 2011 Norway 1858 64 23.8 48.4 57.6 regular 
Veal et al., 2014 [70] 2012 Australia 7309 nk - - 90.7 both 
Veal et al., 2014 [70] 2012 Australia 7309 nk 28.1 - 62.8 regular 
Onder et al., 2014 [77] 2013 Europe not 
including 
Italy 
3608 nk 
- - 
28 both 
Onder et al., 2014 [77] 2013 Italy 3179 nk - - 16 both 
*nk = not known 
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